Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2013

01-08-2013 | Article

Differences in the antibiotic susceptibility of human Escherichia coli with poultry-associated and non-poultry-associated extended-spectrum beta-lactamases

Authors: T. N. Platteel, M. A. Leverstein-Van Hall, J. W. Cohen Stuart, G. M. Voets, M. P. van den Munckhof, J. Scharringa, N. van de Sande, A. C. Fluit, M. J. M. Bonten, on behalf of the ESBL National Surveillance Working Group

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2013

Login to get access

Abstract

The concurrent presence of bla CTX-M-1 and bla TEM-52 genes on similar plasmids of Escherichia coli isolated from poultry, chicken meat and humans supports the occurrence of food-borne transmission of extended-spectrum beta-lactamase (ESBL) genes. ESBL-producing E. coli (ESBL-E. coli) are most frequently detected in hospitalised patients and are known to spread in healthcare settings. We hypothesised that poultry-associated (PA) ESBL genes are predominant in the community, where acquisition is fuelled by food contamination, whereas non-PA ESBL genes are predominant in hospitals, with acquisition fuelled by cross-transmission. Then, differences in antimicrobial selective pressure in hospitals and poultry would create differences in co-resistance between PA and non-PA ESBL-E. coli. We, therefore, determined the prevalence and co-resistance of PA and non-PA ESBL-E. coli in community-acquired and nosocomial urinary tract infections in humans and bla CTX-M-1 and bla TEM-52 isolates from poultry. A total of 134 human ESBL-E. coli urine isolates were included in this study. Isolates containing bla CTX-M-1 or bla TEM-52 were considered to be PA, with the remainder being non-PA. Also, 72 poultry ESBL-E. coli were included. Minimum inhibitory concentration (MIC) values were determined by broth microdilution. The prevalence of PA ESBL genes in isolates obtained in general practice and hospitals was 28 % versus 30 % (n.s.). Human PA ESBL-E. coli were more frequently susceptible to ciprofloxacin (51 % vs. 25 %; p = 0.0056), gentamicin (86 % vs. 63 %; p = .0.0082), tobramycin (91 % vs. 34 %; p = 0.0001) and amikacin (98 % vs. 67 %; p = 0.0001) compared to human non-PA ESBL-E. coli. PA ESBL-E. coli are not more prevalent in community acquired than nosocomial urine samples, but are more often susceptible to ciprofloxacin and aminoglycosides than non-PA ESBL-E. coli. This does not support the existence of different reservoirs of ESBL genes.
Literature
1.
go back to reference Woerther PL, Angebault C, Lescat M, Ruppé E, Skurnik D, Mniai AE et al (2010) Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population. J Infect Dis 202:515–523PubMedCrossRef Woerther PL, Angebault C, Lescat M, Ruppé E, Skurnik D, Mniai AE et al (2010) Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population. J Infect Dis 202:515–523PubMedCrossRef
2.
go back to reference Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A et al (2011) Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 17:873–880PubMedCrossRef Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A et al (2011) Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 17:873–880PubMedCrossRef
3.
go back to reference Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P et al (2011) Extended-spectrum beta-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis 17:1216–1222PubMedCrossRef Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P et al (2011) Extended-spectrum beta-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis 17:1216–1222PubMedCrossRef
4.
go back to reference Platteel TN, Cohen Stuart JW, de Neeling AJ, Voets GM, Scharringa J, van de Sande N et al (2013) Multi-centre evaluation of a phenotypic extended spectrum beta-lactamase detection guideline in the routine setting. Clin Microbiol Infect 19:70–76PubMedCrossRef Platteel TN, Cohen Stuart JW, de Neeling AJ, Voets GM, Scharringa J, van de Sande N et al (2013) Multi-centre evaluation of a phenotypic extended spectrum beta-lactamase detection guideline in the routine setting. Clin Microbiol Infect 19:70–76PubMedCrossRef
5.
go back to reference Voets GM, Fluit AC, Scharringa J, Cohen Stuart J, Leverstein-van Hall MA (2011) A set of multiplex PCRs for genotypic detection of extended-spectrum beta-lactamases, carbapenemases, plasmid-mediated AmpC beta-lactamases and OXA beta-lactamases. Int J Antimicrob Agents 37:356–359PubMedCrossRef Voets GM, Fluit AC, Scharringa J, Cohen Stuart J, Leverstein-van Hall MA (2011) A set of multiplex PCRs for genotypic detection of extended-spectrum beta-lactamases, carbapenemases, plasmid-mediated AmpC beta-lactamases and OXA beta-lactamases. Int J Antimicrob Agents 37:356–359PubMedCrossRef
6.
go back to reference Central Institute for Animal Disease Control (CIDC) CIfADC. MARAN 2009. Monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2009. Lelystad, The Netherlands Central Institute for Animal Disease Control (CIDC) CIfADC. MARAN 2009. Monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2009. Lelystad, The Netherlands
7.
go back to reference Nys S, van Merode T, Bartelds AI, Stobberingh EE (2006) Antibiotic treatment and resistance of unselected uropathogens in the elderly. Int J Antimicrob Agents 27:236–241PubMedCrossRef Nys S, van Merode T, Bartelds AI, Stobberingh EE (2006) Antibiotic treatment and resistance of unselected uropathogens in the elderly. Int J Antimicrob Agents 27:236–241PubMedCrossRef
8.
go back to reference Nys S, van Merode T, Bartelds AI, Stobberingh EE (2006) Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture. J Antimicrob Chemother 57:955–958PubMedCrossRef Nys S, van Merode T, Bartelds AI, Stobberingh EE (2006) Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture. J Antimicrob Chemother 57:955–958PubMedCrossRef
9.
go back to reference den Heijer CDJ, Donker GA, Maes J, Stobberingh EE (2010) Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J Antimicrob Chemother 65:2128–2133CrossRef den Heijer CDJ, Donker GA, Maes J, Stobberingh EE (2010) Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J Antimicrob Chemother 65:2128–2133CrossRef
10.
go back to reference Knottnerus BJ, Nys S, Ter Riet G, Donker G, Geerlings SE, Stobberingh E (2008) Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? J Antimicrob Chemother 62:356–359PubMedCrossRef Knottnerus BJ, Nys S, Ter Riet G, Donker G, Geerlings SE, Stobberingh E (2008) Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? J Antimicrob Chemother 62:356–359PubMedCrossRef
Metadata
Title
Differences in the antibiotic susceptibility of human Escherichia coli with poultry-associated and non-poultry-associated extended-spectrum beta-lactamases
Authors
T. N. Platteel
M. A. Leverstein-Van Hall
J. W. Cohen Stuart
G. M. Voets
M. P. van den Munckhof
J. Scharringa
N. van de Sande
A. C. Fluit
M. J. M. Bonten
on behalf of the ESBL National Surveillance Working Group
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-013-1855-3

Other articles of this Issue 8/2013

European Journal of Clinical Microbiology & Infectious Diseases 8/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.